Advanced search
Publication Cover
Cancer Investigation Volume 23, 2005 - Issue 2
Submit an article Journal homepage
217
Views
19
CrossRef citations to date
0
Altmetric
New Drugs

Preclinical and Clinical Experience with Fulvestrant (Faslodex) in Postmenopausal Women with Hormone Receptor-Positive Advanced Breast Cancer

Professor Nigel Bundred Department of Surgery, South Manchester University Hospital, University of Manchester, Manchester, UK; Department of Surgery, South Manchester University Hospital, University of Manchester, Education and Research Building, 2nd Floor, Southmoor Road, Manchester, M23 9LT, UK
, M.D.
Pages 173-181 | Published online: 11 Jun 2009

Citations (19)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

G. H. Jansen, H. R. Franke, F. Wolbers, M. Brinkhuis & I. Vermes. (2008) Effects of fulvestrant alone or combined with different steroids in human breast cancer cells in vitro. Climacteric 11:4, pages 315-321.
Read now

Articles from other publishers (18)

Linlin Li, Xiaoyu Chen, Congcong Pei, Jingya Li, Dapeng Zou, Yangjie Wu & Yusheng Wu. (2021) Visible-light-mediated direct C-H perfluoroalkylation of imidazoheterocycles. Tetrahedron Letters 83, pages 153407.
Crossref
Myles Brown, Laura Cato & Rinath Jeselsohn. 2019. Yen and Jaffe's Reproductive Endocrinology. Yen and Jaffe's Reproductive Endocrinology 717 741.e8 .
Gao Chanchan, Su Xiangyu, Shi Fangfang, Chen Yan & Gu Xiaoyi. (2018) The efficacy and safety of targeted therapy plus fulvestrant in postmenopausal women with hormone-receptor positive advanced breast cancer: A meta-analysis of randomized-control trials. PLOS ONE 13:9, pages e0204202.
Crossref
Nora S Sánchez, Gordon B Mills & Kenna R Mills Shaw. (2017) Precision oncology: neither a silver bullet nor a dream. Pharmacogenomics 18:16, pages 1525-1539.
Crossref
Clara I Lee, Annabel Goodwin & Nicholas Wilcken. (2017) Fulvestrant for hormone-sensitive metastatic breast cancer. Cochrane Database of Systematic Reviews 2017:1.
Crossref
Jiawang Liu, Shilong Zheng, Victoria L. Akerstrom, Chester Yuan, Youning Ma, Qiu Zhong, Changde Zhang, Qiang Zhang, Shanchun Guo, Peng Ma, Elena V. Skripnikova, Melyssa R. Bratton, Antonio Pannuti, Lucio Miele, Thomas E. Wiese & Guangdi Wang. (2016) Fulvestrant-3 Boronic Acid (ZB716): An Orally Bioavailable Selective Estrogen Receptor Downregulator (SERD). Journal of Medicinal Chemistry 59:17, pages 8134-8140.
Crossref
Clara I Lee, Annabel Goodwin, Orit Freedman, Mark Clemons & Nicholas Wilcken. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Richard J. Santen, Linda R. Duska & Stephen H. Culp. 2014. Yen & Jaffe's Reproductive Endocrinology. Yen & Jaffe's Reproductive Endocrinology 651 698.e14 .
Patricia de Cremoux. (2011) Hormonothérapie des cancers du sein. Bulletin du Cancer 98:11, pages 1311-1319.
Crossref
T. Delozier. (2010) Hormonothérapie du cancer du sein. Journal de Gynécologie Obstétrique et Biologie de la Reproduction 39:8, pages F71-F78.
Crossref
Orit Freedman, Eitan Amir, George Dranitsaris, Julie Napolskikh, Ritu Kumar, Michael Fralick, Stephen Chia, Teresa Petrella, Susan Dent, Katia Tonkin, Imran Ahmad, Daniel Rayson & Mark Clemons. (2009) Predicting benefit from fulvestrant in pretreated metastatic breast cancer patients. Breast Cancer Research and Treatment 118:2, pages 377-383.
Crossref
Richard J. Santen. 2009. Yen & Jaffe's Reproductive Endocrinology. Yen & Jaffe's Reproductive Endocrinology 659 686 .
Nikolay V. Dimitrov, Sunil Nagpal & Shalini Chitneni. (2008) Management of male breast cancer. Oncology Reviews 2:1, pages 44-52.
Crossref
Nikolay V. Dimitrov, Philomena Colucci & Sunil Nagpal. (2007) Some Aspects of the Endocrine Profile and Management of Hormone-Dependent Male Breast Cancer. The Oncologist 12:7, pages 798-807.
Crossref
William J. Gradishar. (2007) Update on fulvestrant for hormone receptor-positive advanced breast cancer. Community Oncology 4:4, pages 220-231.
Crossref
Victoria J. Findlay. 2007. xPharm: The Comprehensive Pharmacology Reference. xPharm: The Comprehensive Pharmacology Reference 1 5 .
Gianfilippo Bertelli & Robert Paridaens. (2006) Optimal sequence of hormonotherapy in advanced breast cancer. Current Opinion in Oncology 18:6, pages 572-577.
Crossref
Gianfilippo Bertelli, Ornella Garrone, Marco Merlano, Marcella Occelli, Laura Bertolotti, Federico Castiglione, Fiorella Pepi, Ornella Fusco, Lucia Del Mastro & Robert C.F. Leonard. (2005) Sequential Treatment with Exemestane and Non-Steroidal Aromatase Inhibitors in Advanced Breast Cancer. Oncology 69:6, pages 471-477.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.